New research shows that women who have taken the oral contraceptive pill are less likely to have colorectal cancer, endometrial cancer or ovarian cancer for up to thirty years.
For the study, published Feb. 8 in the American Journal of Obstetrics and Gynecology, researchers from The University of Aberdeen followed 46,000 women for up to 44 years. So far, this has been the longest-running study looking into the effects of the pill.
“Because the study has been going for such a long time we are able to look at the very long term effects, if there are any, associated with the pill,” said Dr. Lisa Iversen, lead author of the study. “The protective benefits from using the pill during their reproductive years are lasting for at least 30 years after women have stopped using the pill.”
Funding was provided by the Royal College of General Practitioners, Medical Research Council and the Imperial Cancer Research Fund. The study authors reported no conflict of interest.